27939374|t|Mesenchymal stromal cell - secreted chemerin is a novel immunomodulatory molecule driving the migration of ChemR23 - expressing cells
27939374|a|Mesenchymal stromal cells (MSCs) are multipotent cells characterized by broad immunomodulatory properties exploited for the treatment of inflammatory disorders. However, the efficacy of MSC -based therapy is highly variable and tightly linked to MSC culture conditions and treatment schedule. Thus, the identification of novel key molecules regulating MSC immunomodulatory activities in vivo might constitute a crucial step toward the optimization of currently available clinical protocols. In this regard, herein, we sought to determine whether the newly identified chemotactic protein, chemerin, plays a role in MSC -mediated regulation of inflammation. Chemerin production by human MSCs was investigated under different culture conditions using enzyme-linked immunosorbent assay (ELISA). After purification, MSC - secreted chemerin was identified using mass spectrometry analysis and the biological activity of secreted isoforms was evaluated using migration assay. Bone marrow - derived MSCs secrete chemerin and express its receptors ChemR23 and CCRL2. Chemerin production is dependent on culture conditions and increases upon stimulation with inflammatory cytokines. In particular, platelet lysate (PL)- MSCs produce higher levels of chemerin compared with fetal bovine serum (FBS)- MSCs. Furthermore, chemerin is secreted by MSCs as an inactive precursor, which can be converted into its active form by exogenous chemerin - activating serine and cysteine proteases. Our data indicate that, in response to various inflammatory stimuli, MSCs secrete high amounts of inactive chemerin, which can then be activated by inflammation - induced tissue proteases. In light of these initial findings, we propose that further analysis of chemerin functions in vivo might constitute a crucial step toward optimizing MSC -based therapy for inflammatory diseases.
27939374	0	24	Mesenchymal stromal cell	T017	UMLS:C3178844
27939374	27	35	secreted	T038	UMLS:C1327616
27939374	36	44	chemerin	T103	UMLS:C1312957
27939374	56	81	immunomodulatory molecule	T058	UMLS:C1963758
27939374	94	103	migration	T038	UMLS:C1533574
27939374	107	114	ChemR23	T103	UMLS:C1307877
27939374	134	159	Mesenchymal stromal cells	T017	UMLS:C3178844
27939374	161	165	MSCs	T017	UMLS:C3178844
27939374	171	188	multipotent cells	T017	UMLS:C1136335
27939374	212	239	immunomodulatory properties	T058	UMLS:C1963758
27939374	258	267	treatment	T058	UMLS:C0087111
27939374	271	293	inflammatory disorders	T038	UMLS:C1290884
27939374	320	323	MSC	T017	UMLS:C3178844
27939374	331	338	therapy	T058	UMLS:C0087111
27939374	380	383	MSC	T017	UMLS:C3178844
27939374	384	402	culture conditions	T058	UMLS:C0007585
27939374	407	425	treatment schedule	T058	UMLS:C0040808
27939374	461	474	key molecules	T103	UMLS:C0574031
27939374	486	489	MSC	T017	UMLS:C3178844
27939374	490	517	immunomodulatory activities	T058	UMLS:C1963758
27939374	518	525	in vivo	T082	UMLS:C1515655
27939374	605	623	clinical protocols	T058	UMLS:C0008971
27939374	701	730	chemotactic protein, chemerin	T103	UMLS:C1312957
27939374	748	751	MSC	T017	UMLS:C3178844
27939374	762	772	regulation	T038	UMLS:C1327622
27939374	776	788	inflammation	T038	UMLS:C0021368
27939374	790	798	Chemerin	T103	UMLS:C1312957
27939374	813	818	human	T204	UMLS:C0086418
27939374	819	823	MSCs	T017	UMLS:C3178844
27939374	857	875	culture conditions	T058	UMLS:C0007585
27939374	882	915	enzyme-linked immunosorbent assay	T058	UMLS:C0014441
27939374	917	922	ELISA	T058	UMLS:C0014441
27939374	945	948	MSC	T017	UMLS:C3178844
27939374	951	959	secreted	T038	UMLS:C1327616
27939374	960	968	chemerin	T103	UMLS:C1312957
27939374	990	1007	mass spectrometry	T058	UMLS:C0037813
27939374	1008	1016	analysis	T062	UMLS:C0936012
27939374	1048	1056	secreted	T038	UMLS:C1327616
27939374	1057	1065	isoforms	T103	UMLS:C0597298
27939374	1086	1101	migration assay	T058	UMLS:C1513300
27939374	1103	1114	Bone marrow	T017	UMLS:C0005953
27939374	1125	1129	MSCs	T017	UMLS:C3178844
27939374	1130	1137	secrete	T038	UMLS:C1327616
27939374	1138	1146	chemerin	T103	UMLS:C1312957
27939374	1163	1180	receptors ChemR23	T103	UMLS:C1307877
27939374	1185	1190	CCRL2	T103	UMLS:C1453427
27939374	1192	1200	Chemerin	T103	UMLS:C1312957
27939374	1228	1246	culture conditions	T058	UMLS:C0007585
27939374	1266	1277	stimulation	T058	UMLS:C1292856
27939374	1296	1305	cytokines	T038	UMLS:C0010813
27939374	1322	1337	platelet lysate	T017	UMLS:C0005821
27939374	1344	1348	MSCs	T017	UMLS:C3178844
27939374	1374	1382	chemerin	T103	UMLS:C1312957
27939374	1397	1415	fetal bovine serum	T103	UMLS:C3812213
27939374	1417	1420	FBS	T103	UMLS:C3812213
27939374	1423	1427	MSCs	T017	UMLS:C3178844
27939374	1442	1450	chemerin	T103	UMLS:C1312957
27939374	1454	1462	secreted	T038	UMLS:C1327616
27939374	1466	1470	MSCs	T017	UMLS:C3178844
27939374	1554	1562	chemerin	T103	UMLS:C1312957
27939374	1576	1582	serine	T103	UMLS:C2717971
27939374	1587	1605	cysteine proteases	T103	UMLS:C0769345
27939374	1676	1680	MSCs	T017	UMLS:C3178844
27939374	1681	1688	secrete	T038	UMLS:C1327616
27939374	1714	1722	chemerin	T103	UMLS:C1312957
27939374	1755	1767	inflammation	T038	UMLS:C0021368
27939374	1778	1784	tissue	T017	UMLS:C0040300
27939374	1785	1794	proteases	T103	UMLS:C0030940
27939374	1822	1830	findings	T033	UMLS:C0243095
27939374	1856	1864	analysis	T062	UMLS:C0936012
27939374	1868	1876	chemerin	T103	UMLS:C1312957
27939374	1887	1894	in vivo	T082	UMLS:C1515655
27939374	1945	1948	MSC	T017	UMLS:C3178844
27939374	1956	1963	therapy	T058	UMLS:C0087111
27939374	1968	1989	inflammatory diseases	T038	UMLS:C1290884